Alan S. Hazell

2335 Bennett Avenue
Montreal, QC H1V2T6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage.

Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage.

Journal: Neurochemical research

Published: February 24, 2023

Region-selective permeability of the blood-brain barrier to α-aminoisobutyric acid during thiamine deficiency and following its reversal.

Region-selective permeability of the blood-brain barrier to α-aminoisobutyric acid during thiamine deficiency and following its reversal.

Journal: Metabolic brain disease

Published: June 17, 2020

Potential for stem cell treatment in manganism.

Potential for stem cell treatment in manganism.

Journal: Neurochemistry international

Published: April 21, 2017

Treatment of rats with the JAK-2 inhibitor fedratinib does not lead to experimental Wernicke's encephalopathy.

Treatment of rats with the JAK-2 inhibitor fedratinib does not lead to experimental Wernicke's encephalopathy.

Journal: Neuroscience letters

Published: October 02, 2016

Acute liver failure is associated with altered cerebral expression profiles of long non-coding RNAs.

Acute liver failure is associated with altered cerebral expression profiles of long non-coding RNAs.

Journal: Neuroscience letters

Published: August 30, 2016

The Vegetative State and Stem Cells: Therapeutic Considerations.

The Vegetative State and Stem Cells: Therapeutic Considerations.

Journal: Frontiers in neurology

Published: February 25, 2016

Erratum to: Acute liver failure-induced hepatic encephalopathy is associated with changes in microRNA expression profiles in cerebral cortex of the mouse.

Erratum to: Acute liver failure-induced hepatic encephalopathy is associated with changes in microRNA expression profiles in cerebral cortex of the mouse.

Journal: Metabolic brain disease

Published: December 25, 2014

Mechanisms of hepatic encephalopathy and thiamine deficiency.

Mechanisms of hepatic encephalopathy and thiamine deficiency.

Journal: Metabolic brain disease

Published: June 29, 2014

Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Journal: Neurochemical research

Published: June 04, 2014

Thiamine deficiency results in release of soluble factors that disrupt mitochondrial membrane potential and downregulate the glutamate transporter splice-variant GLT-1b in cultured astrocytes.

Thiamine deficiency results in release of soluble factors that disrupt mitochondrial membrane potential and downregulate the glutamate transporter splice-variant GLT-1b in cultured astrocytes.

Journal: Biochemical and biophysical research communications

Published: April 02, 2014

Role of astrocytes in thiamine deficiency.

Role of astrocytes in thiamine deficiency.

Journal: Metabolic brain disease

Published: March 11, 2014

Acute liver failure-induced hepatic encephalopathy s associated with changes in microRNA expression rofiles in cerebral cortex of the mouse [corrected].

Acute liver failure-induced hepatic encephalopathy s associated with changes in microRNA expression rofiles in cerebral cortex of the mouse [corrected].

Journal: Metabolic brain disease

Published: February 21, 2014

Showing 1-12 of 24

Last Updated: 09/26/2026